The Canadian Securities Exchange (CSE) revealed that in April this year CSE issuers completed 85 financings that raised around C$1 billion - the fourth largest monthly total in the Exchange's history.
The trading volume of CSE-listed securities totaled 3.4 billion shares, while the trading value of CSE-listed securities was C$3.7 billion.
"The CSE continues to build on its strength as the stock exchange of choice for successful entrepreneurs," said Richard Carleton, CSE chief executive in a statement.
"In the first four months of 2021, the Exchange added 63 new listings. We are highly impressed with the potential of the companies coming to market across a wide variety of industries. We will continue to provide entrepreneurial firms with the innovative, market-leading support they need."
There were 19 new listings last month, bringing total CSE listings to 658 and the total market value of CSE issuers was C$63.9 billion as at April 30, 2021, compared to C$42.1 billion at the end of 2020.
Among the new listings was Emerald Health Therapeutics Inc (EMH), Ayurcann Holdings Corp (AYUR) and Black Shield Metals Corp (BDX)
The Exchange noted that during the month of May, 2021, the CSE is presenting the Cannabis Investor Series, a four-episode virtual series that explores key facets of the rapidly-evolving cannabis industry.
The episodes take place on Tuesdays from 2pm to 4pm ET.
The CSE says it offers investors in Canada and abroad access to a multi-sector collection of growth companies through a liquid, reliable and highly regulated trading platform.
Contact the author at giles@proactiveinvestors.com